Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federica Perrone

Showing results (131-140 of 160) with videos related to

Pageof 16
Sort By:
Neurobiology of Aging|January 11, 2017
Investigating the role of ALS genes CHCHD10 and TUBA4A in Belgian FTD-ALS spectrum patientsFederica Perrone, Hung Phuoc Nguyen, Sara Van Mossevelde, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2016
Heterogeneity of Acquired Resistance to Anti-EGFR Monoclonal Antibodies in Patients with Metastatic Colorectal CancerFilippo Pietrantonio, Claudio Vernieri, Giulia Siravegna, et al.
Cellular Oncology (Dordrecht, Netherlands)|November 19, 2020
AKR1C3 is a biomarker and druggable target for oropharyngeal tumorsCaterina Peraldo-Neia, Paola Ostano, Maurizia Mello-Grand, et al.
Cell Reports|August 29, 2024
Antigenic sin and multiple breakthrough infections drive converging evolution of COVID-19 neutralizing responsesIda Paciello, Giulio Pierleoni, Elisa Pantano, et al.
European Journal of Cancer (Oxford, England : 1990)|August 11, 2024
Sunitinib for the treatment of patients with advanced pheochromocytomas or paragangliomas: The phase 2 non-randomized SUTNET clinical trialVincenzo Nasca, Natalie Prinzi, Jorgelina Coppa, et al.
Scientific Reports|March 1, 2019
Prognostic impact of ATM mutations in patients with metastatic colorectal cancerGiovanni Randon, Giovanni Fucà, Daniele Rossini, et al.
European Journal of Cancer (Oxford, England : 1990)|May 18, 2025
Clinical evaluation of the role of miRNA 371 in small testicular masses. Results of the "S1STeM 371" TrialSebastiano Nazzani, Adele Busico, Valentina Bernasconi, et al.
BMJ Open|May 16, 2025
Impact of comprehensive genomic profiling and molecular tumour board on costs and access to tailored therapies: real-world observational studyValentina De Micheli, Luca Agnelli, Elena Conca, et al.
Tumori|September 23, 2024
Is tumour sequencing effective for the identification of germline <i>BRCA1/2</i> pathogenic variant carriers?Jacopo Azzollini, Iolanda Capone, Matteo Duca, et al.
The American Journal of Pathology|January 17, 2009
EML4-ALK rearrangement in non-small cell lung cancer and non-tumor lung tissuesMaria Paola Martelli, Gabriella Sozzi, Luis Hernandez, et al.
Pageof 16

Showing results (131-140 of 160) with videos related to

Sort By:
Pageof 16
Neurobiology of Aging|January 11, 2017
Investigating the role of ALS genes CHCHD10 and TUBA4A in Belgian FTD-ALS spectrum patientsFederica Perrone, Hung Phuoc Nguyen, Sara Van Mossevelde, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2016
Heterogeneity of Acquired Resistance to Anti-EGFR Monoclonal Antibodies in Patients with Metastatic Colorectal CancerFilippo Pietrantonio, Claudio Vernieri, Giulia Siravegna, et al.
Cellular Oncology (Dordrecht, Netherlands)|November 19, 2020
AKR1C3 is a biomarker and druggable target for oropharyngeal tumorsCaterina Peraldo-Neia, Paola Ostano, Maurizia Mello-Grand, et al.
Cell Reports|August 29, 2024
Antigenic sin and multiple breakthrough infections drive converging evolution of COVID-19 neutralizing responsesIda Paciello, Giulio Pierleoni, Elisa Pantano, et al.
European Journal of Cancer (Oxford, England : 1990)|August 11, 2024
Sunitinib for the treatment of patients with advanced pheochromocytomas or paragangliomas: The phase 2 non-randomized SUTNET clinical trialVincenzo Nasca, Natalie Prinzi, Jorgelina Coppa, et al.
Scientific Reports|March 1, 2019
Prognostic impact of ATM mutations in patients with metastatic colorectal cancerGiovanni Randon, Giovanni Fucà, Daniele Rossini, et al.
European Journal of Cancer (Oxford, England : 1990)|May 18, 2025
Clinical evaluation of the role of miRNA 371 in small testicular masses. Results of the "S1STeM 371" TrialSebastiano Nazzani, Adele Busico, Valentina Bernasconi, et al.
BMJ Open|May 16, 2025
Impact of comprehensive genomic profiling and molecular tumour board on costs and access to tailored therapies: real-world observational studyValentina De Micheli, Luca Agnelli, Elena Conca, et al.
Tumori|September 23, 2024
Is tumour sequencing effective for the identification of germline <i>BRCA1/2</i> pathogenic variant carriers?Jacopo Azzollini, Iolanda Capone, Matteo Duca, et al.
The American Journal of Pathology|January 17, 2009
EML4-ALK rearrangement in non-small cell lung cancer and non-tumor lung tissuesMaria Paola Martelli, Gabriella Sozzi, Luis Hernandez, et al.
Pageof 16